This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Longchamp
Avery, Jill; Junker, Tonia; Beyersdorfer, DanielaCase HBS-316086-EMarketingLongchamp's Le Pliage is one of the fashion world's most successful products, a cultural icon across the globe. But managing the low priced, nylon handbag is challenging as Longchamp tries to move its brand upmarket into higher priced, luxury leather goodStarting at €8.20
-
Bang & Olufsen: la innnovación impulsada por el diseño
Beyersdorfer, Daniela; Austin, Robert D.Case HBS-117S02Service and Operations ManagementUna empresa de éxito, reconocido mundialmente por el exquisito diseño de los productos electrónicos de consumo, se esfuerza por integrar mejor diseño de software en sus procesos de diseño de productos físicos tradicionales para satisfacer las demandas de un mundo post-iPod. Detalla el proceso de Bang & Olufsen "impulsada por el diseño de la innovación", que funciona de manera muy diferente que en los procesos de desarrollo de productos de muchas ...Starting at €8.20
-
Managing Growth (Spanish version)
Huckman, Robert S.; Pisano, Gary P.Case HBS-611S08Service and Operations ManagementConsiders the situation facing David Barger, President and CEO of JetBlue Airways, in May 2007 as he addresses the airline's need to slow its growth rate in the response to increasing fuel costs and the effects of major operational crisis for the airline in February 2007. In 2005, JetBlue-typically viewed as a low-cost carrier (LCC)-made a move that is often considered antithetical to the LCC model. Specifically, JetBlue moved from a single aircr...Starting at €8.20
-
BYD Company, Ltd. (Spanish version)
Huckman, Robert S.; MacCormack, AlanCase HBS-614S03Service and Operations ManagementConsidera si BYD Co., Ltd., el mayor fabricante chino de baterías recargables, debe entrar en la industria del automóvil chino mediante la adquisición de Qinchuan automático, un fabricante de automóviles de propiedad estatal. Establecer justo después de la oferta pública inicial de BYD en la Bolsa de Hong Kong en 2002, que describe el desarrollo del enfoque de trabajo intensivo de BYD para la fabricación de baterías - un enfoque decididamente dif...Starting at €8.20
-
Lotus F1 Team (Spanish Version)
Thomke, Stefan; Trichakis, Nikolaos; Lenhardt, Jerome; Beyersdorfer, DanielaCase HBS-619S11Service and Operations Managementretention of high performing individuals, response to disruptive technological changes, and regulatory design in competitive environments.Starting at €8.20
-
Longchamp (Spanish version)
Avery, Jill; Junker, Tonia; Beyersdorfer, DanielaCase HBS-317S06MarketingLongchamp's Le Pliage is one of the fashion world's most successful products, a cultural icon across the globe. But managing the low priced, nylon handbag is challenging as Longchamp tries to move its brand upmarket into higher priced, luxury leather goods. How much should Longchamp focus on Le Pliage versus its leather handbags? How should the subbrand be distributed, merchandised, priced, and promoted? How does Le Pliage both contribute to and ...Starting at €8.20
-
L'Occitane en Provence
Becker, Bo; Beyersdorfer, Daniela; Mayfield, E. Scott; Yamazaki, MayukaCase HBS-212051-EFinanceCosmetics company L'Occitane en Provence must decide if it is the right time to go public, and, if so, where to list. The firm could list on Euronext in Paris, close to the firm's headquarters in southern France, on one of the large exchanges in the United States, or perhaps in Asia, where much of the firm's future growth is expected. The case provides opportunities to discuss the benefits and costs of going public, including valuation implicatio...Starting at €8.20
-
Innovation and Growth at Actelion Ltd.
Pisano, Gary P.; Beyersdorfer, Daniela; Dittrich, RuthCase HBS-611065-ELeadership and People ManagementIn late 2010, Jean-Paul Clozel, CEO of the Swiss biotech pharmaceuticals firm Actelion, looks back on a successful decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven organisation had grown into one of Europe's largest biotech firms by revenues. Their success was mainly founded on their orphan indication drug Tracleer, which Actelion sold and market...Starting at €8.20
-
New Balance Athletic Shoe, Inc. (Abridged)
Bowen, H. Kent; Huckman, Robert S.; Knoop, Carin-Isabel; Preble, MatthewCase HBS-613006-EService and Operations ManagementConsiders whether New Balance, one of the world's five largest manufacturers of athletic footwear, should respond to Adidas' planned acquisition of Reebok-a transaction that would join the second- and third-largest companies in the industry. Highlights the unique aspects of New Balance's strategy-focusing on fit and performance by offering long-lived shoes in a wide variety of widths and eschewing celebrity endorsement of its products-and discuss...Starting at €8.20
-
Mayo Clinic: The 2020 Initiative
Herzlinger, Regina E.; Huckman, Robert S.; Lesser, JennyCase HBS-615027-EDescribes the challenges facing Dr. John Noseworthy, President and CEO, in implementing a long-term strategy for the growth of the Mayo Clinic-a leading academic medical center with a reputation for excellence in tertiary and quaternary health care. The case highlights the concurrent forces of regional and national competition and federal health care reform as factors complicating the plans of Mayo Clinic to grow through several channels. Student...Starting at €8.20